Next Generation Antibody Therapies Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025
- Transparency Market Research
- Healthcare IT
Antibodies are potent biopharmaceutical agents designed to target specific cells. Many researchers have concentrated their efforts to develop antibodies specific to the antigens present on cancer cells. Research and development in the field of antibodies is progressing rapidly. In the past 25 years, over 30 immunoglobulins (IgGs) and their derivatives have been approved for various indications. The currently approved antibody drugs are used not only to treat diseases that affect large number of patients (such as inflammatory diseases and cancer), but also for indications that require special regulatory procedures.
Antibody production has attracted researchers across the world owing to several advantages such as wider therapeutic window, high efficacy to treat certain diseases, and easy development process. Due to these advantages, the global next generation antibody therapies market is experiencing impressive growth. Research and development is also being carried out to create antibody fragments that only bind and neutralize the target, but do not provoke any immune response in contrast to the full length antibody. Moreover, high number of studies are performed in the area of bispecific antibodies that bind to two different targets.
The global next generation antibody therapies market can be segmented based on type of antibody, application, end-user, and region. In terms of type of antibody, the market can be categorized into antibody-drug conjugates (ADCs), bispecific antibodies, intrabodies, alternative protein scaffold, antibody fragments and single domain antibodies, antibody with modified Fc functions (engineered antibodies), and others. Based on application, the global next generation antibody therapies market can be divided into oncology, autoimmune diseases, and others. In terms of region, the market can be segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The global next generation antibody therapies market is expected to register double digit growth rate owing to increasing efforts by the pharmaceutical and biotechnology companies and research laboratories to develop new antibodies that can treat major diseases such as cancer, rheumatoid arthritis, and other chronic diseases. Additionally, large number of antibody drug conjugates under clinical study is likely to boost market growth in the near future. However, small number of commercially available antibody drug conjugates and high cost limit the uptake of these drugs. This in turn restrains the market. Moreover, stringent government regulations such as those imposed by the U.S. FDA and high cost of production of antibodies are anticipated to hamper the growth of the global next generation antibody therapies market.
North America dominates the global next generation antibody therapies market. Growth of the market in North America is attributed to increasing research and development on antibodies by pharmaceutical and biotechnology companies. Europe is considered to be the second largest market for next generation antibody therapies owing to the strong presence of biotechnology and pharmaceutical companies in the region. Countries in Asia Pacific such as India and China are the emerging markets for next generation antibody production due to rising prevalence of cancer and other chronic diseases, and large population base for conducting clinical trials. Additionally, large number of R&D activities in the region and cost efficient research services contribute to the growth of the market in Asia Pacific.
Major players competing in the global next generation antibody therapies market are Amgen, Inc., AstraZeneca plc, Bristol-Myers Squibb Company, Bayer AG, F. Hoffmann-La Roche Ltd., Genmab A/S, Kyowa Hakko Kirin Co. Ltd., ImmunoGen, Inc., Pfizer, Inc., Seattle Genetics, Inc. and Xencor, Inc.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Have query on this report?Make an Enquiry
The team was the biggest help to us. Not only were we provided with customized solutions but also we were guided through the most complicated situations. The information was on-point yet comprehensive. The experience was absolutely satisfying and helped us turn many challenges into opportunities.
Ours is a startup with a unique set of challenges and we were therefore hesitant but the team totally put us at ease with their knowledge and expertise. Our business and its challenges were understood perfectly and help was extended accordingly. The tailor made approach really helped us gain the most informative insights.
The report repository is absolutely impressive –updated and exhaustive in terms of markets covered and information provides. Besides, with the support extended to us by the team, we could reduce costs as well as move to sustainable growth. This really helped us tap into new opportunities. Happy to have gone ahead with ResearchMos.us.
We have had a long term engagement with ResearchMoz.us and never have we felt that the work done and help extended were below flawless. The report repository is one of the best one can hope to tap into. Recently, our partner businesses opted for consultancy services and they are all thrilled with the outcome.
Insights from reports helped us improve our profit margins significantly. Most of the knowledge we needed on the market were provided to us on a granular basis. From trends, and drivers to competitive analysis, the information was not just crisp but also insightful. That helped us chart a robust growth strategy and as of now we are happy to state that we are reaping big benefits.
More from Healthcare IT
Healthcare ITGlobal mHealth Market Research Report 2016
Pharmaceuticals and HealthcareGlobal Bionic Ears Market Professional Survey Report 2017
Pharmaceuticals and HealthcareNeuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Pharmaceuticals and HealthcareHepatitis Drug Development Pipeline Review, 2017